Position in SRZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,554,584
+$572,655 QoQ
Shares Held
87,696
0.0% QoQ
Ownership
0.755%
of shares outstanding
% of Portfolio
8.69%
of 13F equity value
Holder Rank
#22
of 58 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRZN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Euclidean Capital LLC holds $29,386,023 across 6 Biotechnology names. SRZN ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORIC |
Oric Pharmaceuticals, Inc.
|
989,410 | $12,535,824 | |
| 2 | FHTX |
Foghorn Therapeutics Inc.
|
1,573,761 | $7,522,577 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
|
2,627,643 | $3,258,277 | |
| 4 | ALEC |
Alector, Inc.
|
1,307,858 | $2,811,894 | |
| 5 | SRZN |
Surrozen, Inc./DE
This page
|
87,696 | $2,554,584 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,015,705 | $702,867 |
All Filings in SRZN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,554,584 | 87,696 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,981,929 | 87,696 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,129,962 | 87,696 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $784,002 | 87,696 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,022,535 | 87,696 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,258,437 | 87,696 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,050,598 | 87,696 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $960,271 | 87,696 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,377,704 | 87,696 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $824,342 | 87,696 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||